These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28641048)

  • 21. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
    Sheng R; Li X; Wang Z; Wang X
    Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as prognostic markers in ovarian cancer.
    Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of microRNA in diagnosis and treatment of ovarian cancer.
    Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Nogami Y; Umene K; Masuda K; Kisu I; Nomura H; Kataoka F; Tominaga E; Aoki D
    Biomed Res Int; 2014; 2014():232817. PubMed ID: 24822185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
    Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
    Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review.
    Hulstaert E; Morlion A; Levanon K; Vandesompele J; Mestdagh P
    Gynecol Oncol; 2021 Feb; 160(2):633-642. PubMed ID: 33257015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
    Kuznetsov VA; Tang Z; Ivshina AV
    BMC Genomics; 2017 Oct; 18(Suppl 6):692. PubMed ID: 28984201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
    Ma Y; Lu Y; Lu B
    Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA Theranostics in Prostate Cancer Precision Medicine.
    Matin F; Jeet V; Clements JA; Yousef GM; Batra J
    Clin Chem; 2016 Oct; 62(10):1318-33. PubMed ID: 27540032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA and Ovarian Cancer.
    Langhe R
    Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
    Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical impact of intra- and extracellular miRNAs in ovarian cancer.
    Yoshida K; Yokoi A; Kato T; Ochiya T; Yamamoto Y
    Cancer Sci; 2020 Oct; 111(10):3435-3444. PubMed ID: 32750177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural activities are unfavorable for the prognosis of ovarian cancer through mRNA expression analysis.
    Yang L; Bie L; Sun L; Yue Y
    Biomark Med; 2019 Jun; 13(8):663-673. PubMed ID: 30982327
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer.
    Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW
    Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
    Davidson B; Tropé CG; Reich R
    Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
    Hanžek A; Siatka C; Duc AE
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular features as promising biomarkers in ovarian cancer.
    Bukłaho PA; Kiśluk J; Wasilewska N; Nikliński J
    Adv Clin Exp Med; 2023 Sep; 32(9):1029-1040. PubMed ID: 36920264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.
    Kleemann M; Bereuther J; Fischer S; Marquart K; Hänle S; Unger K; Jendrossek V; Riedel CU; Handrick R; Otte K
    Oncotarget; 2017 Mar; 8(12):18773-18791. PubMed ID: 27821806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.